To investigate the cellular and molecular etiology of early onset torsion dystonia, we have established a Drosophila model of this disorder. Expression of mutant human torsinA deleted for a single glutamic acid residue (DE HtorA), but not normal HtorA, elicits locomotor defects in Drosophila. As in mammalian systems, DE HtorA in flies forms protein accumulations that localize to synaptic membranes, nuclei and endosomes. Various morphological defects at the neuromuscular junction in larvae expressing DE HtorA were observed at the EM level, some of which resemble those recently reported for mutants with defects in TGF-b signaling. These results together with the distribution patterns and localizations of DE HtorA accumulations suggested that DE HtorA could interfere with some aspect of TGF-b signaling from synapses to endosomes or nuclei. Consistent with this possibility, neuronal overexpression of Drosophila or human Smad2, a downstream effector of the TGF-b pathway, suppressed the behavioral and ultrastructural defects of DE HtorA flies. These results raise the possibility that a defect in TGF-b signaling might also underlie early onset torsion dystonia in humans.
INTRODUCTION
Dystonia, the third most common movement disorder in humans, is characterized by sustained involuntary muscle contractions resulting in severe twisting movements and abnormal postures. Although there are a number of heritable forms of dystonia, the most common and severe form is early onset torsion dystonia, a neurological disorder affecting the central nervous system. It is inherited in autosomal dominant fashion with variable penetrance. About 30-40% of heterozygotes manifest the disease with onset between 1 and 28 years of age (1 -3) . Although the cellular and molecular etiology of torsion dystonia is unknown, it is not associated with any obvious neurodegeneration (4, 5) . Recently, this form of dystonia has been linked to the DYT1 gene (6) . The causative mutation is a 3 bp deletion that results in deletion of a glutamic acid (DE302/303) residue near the C-terminus of the encoded protein, Torsin A (HtorA). Another study in a patient with early onset dystonia and early onset Parkinson disease with myoclonic features revealed the presence of an 18 bp deletion mutation in the DYT1 gene that resulted in deletion of six amino acids (DF323-Y328) in HtorA (7) .
Sequence comparisons demonstrate that HtorA is a member of the HSP100/Clp family of ATP-dependent chaperones that functions in the assembly, disassembly and operation of a variety of protein complexes including those involved in many types of vesicular transport (8) . Immunolocalization of HtorA expressed in transfected cell lines suggests that it is a lumenally oriented protein localized to the intracellular membranes of the endoplasmic reticulum (ER). DE HtorA has been found in large spheroid intracellular structures that do not colocalize with ER markers (9) . At the EM level, it was reported that DE TorsinA was found in membrane whorls that may derive from ER (10) . In addition, HtorA is localized in Lewy bodies in postmortem Parkinson disease patients (11, 12) . Expression of normal HtorA in cultured cells resulted in colocalization with various heat shock proteins and suppressed a-synuclein aggregation. However, expression of DE HtorA did not suppress a-synuclein aggregation (13) . Similarly, expression of normal HtorA suppressed polyglutamineinduced protein aggregation in Caenorhabditis elegans (14) . These observations suggest that HtorA could function as a chaperone involved in the folding or processing of secreted or membrane proteins. The effects of the DE mutation on HtorA functions are unknown although the dominant phenotype together with other observations suggests that the mutant protein has a dominant negative or gain-of-function mode of action. The basis of the variable penetrance of early onset torsion dystonia caused by DE HtorA is still Human Molecular Genetics, Vol. 13 2019-2030 doi:10.1093/hmg/ddh208 Advance Access published on July 21, 2004 unclear. A 'second-hit' model in which other genetic mutations or environmental factors increase the susceptibilities of individuals heterozygous for the DE HtorA mutation has been proposed (9, 15, 16) .
As Drosophila offers many experimental advantages for genetic and molecular studies, while the basic molecular components and neuronal signaling mechanisms are evolutionarily conserved (17 -19) , it is increasingly being used as a model system to study human neurological disorders. Here, we have established a Drosophila model of early onset torsion dystonia that may increase our understanding of the molecular and cellular mechanisms responsible for this disorder. Several lines of evidences from this study suggest that the behavioral and ultrastructural abnormalities observed in DE HtorAexpressing flies involve impaired TGF-b signaling. Therefore, we propose that a defect in TGF-b signaling may also contribute to the etiology of early onset torsion dystonia in humans.
RESULTS

Transgenic expression of human TorsinA in Drosophila
To develop a model of early onset torsion dystonia in Drosophila, we used the Gal4/UAS system (20) to express human cDNAs encoding wild-type (WT) or DF323 -Y328 (DFY) (7) or DE302/303 (DE) (6) mutant forms of HtorA in transgenic flies. We used the C155-Gal4 driver (21) and the 3,4-dihydroxyphenylalanine-L-decarboxylase (Ddc)-Gal4 driver (22) , respectively, to drive expression of these constructs either pan-neuronally or specifically in dopaminergic neurons.
To characterize anti-HtorA antiserum and various UASHtorA transgenic flies, expression of WT HtorA proteins by Ddc-Gal4 drivers was examined using goat-anti-HtorA antiserum (Fig. 1A) . Strong immunolabeling was observed in dopaminergic neurons in ventral nerve cords (Fig. 1A1) . No staining was observed in larvae carrying the driver (Ddc-Gal4/ þ) alone (Fig. 1A2) . Preincubation of the anti-HtorA antiserum with HtorA peptides also eliminated staining (Fig. 1A3) .
Examples of WT and mutant HtorA expression in individual dopaminergic neurons in the ventral nerve cord are shown in Figure 1B -D. Comparable levels of expression were observed for each of the different HtorA constructs in two independent transgenic lines for each construct (Fig. 1B1 -D2 ). A striking difference was apparent in the immunolocalization patterns of DE HtorA compared with WT or DFY HtorA (Fig. 1B-D) . WT and DFY HtorA are distributed diffusely throughout the cytoplasm (Fig. 1B and C) , whereas DE HtorA formed distinct cytoplasmic clusters or aggregates localized in proximity to the nuclear membrane and the plasma membrane (Fig. 1D) . The same DE HtorA clusters were observed using two independent anti-HtorA antisera (Supplementary Material, Fig. S1 ). These distribution patterns are similar to those that have been reported for expression of WT and mutant HtorA in transfected human cells cultured in vitro (10, 23) . Thus, the aberrant localization of the DE HtorA into clusters can be recapitulated when expressed in vivo in Drosophila. When expression of WT, DFY and DE HtorA constructs was driven postsynaptically by the muscle-specific C57-Gal4 driver (24) , the proteins showed distribution patterns similar to those in neurons ( Fig. 3A and B Fig. S2 ). Similar results were reported from human cell culture experiments (23) .
Expression of DE HtorA in Drosophila results in behavioral abnormalities
Expression of WT, DFY and DE HtorA in neurons of the adult CNS gave results similar to those observed in larvae. WT and DFY HtorA proteins are distributed broadly throughout the cytoplasm in adult neurons, whereas DE HtorA forms dense accumulations that cluster around membranes (Supplementary Material, Fig. S3A -D) .
Transgenic flies expressing WT or mutant forms of HtorA showed normal life spans when raised at 258C (Supplementary Material, Fig. S4 ) or 308C (data not shown), and did not manifest any overt behavioral deficits under those conditions, whether expression was in dopaminergic neurons only, in all neurons or in muscles. Similar observations were reported by Muraro and Moffat (9th European Drosophila neurobiology meeting abstract, 2002). These data suggested that the presence of clusters of DE HtorA proteins in neurons or muscles might be not sufficient to induce behavioral abnormalities. To explain the 30 -40% penetrance of the DE HtorA mutation in humans, a second-hit model has been proposed according to which environmental factors or other genetic mutations are required to evoke severe behavioral abnormalities (9, 15, 16) . Therefore, we hypothesized that another factor may be required to induce behavioral defects in flies expressing DE HtorA.
In previous studies we have found that a number of mutants in Drosophila with defects in neuronal membrane excitability or synaptic transmission behave normally at room temperature (20 -258C), but show severe locomotor defects such as paralysis or seizures when placed at elevated temperatures (25) . Therefore, we tested whether exposing the HtorA-expressing flies to 388C uncovered any latent behavioral defects (Fig. 2) . We monitored flies at 388C for a period of 10 min and counted the number of flies remaining active on the sides or top of the vial versus those remaining on the bottom at each time point.
Flies expressing DE HtorA in a pan-neural pattern showed striking differences in behavior compared with the control flies or those expressing WT HtorA, and these abnormalities became even more pronounced with age ( Fig. 2A) . Impaired locomotor control at 388C was already apparent in 3-day-old DE HtorA flies compared with controls. By 6 days of age, 90% of DE HtorA-expressing flies became severely incapacitated within 1 min of exposure to 388C exhibiting convulsivelike leg and wing movements suggestive of the aberrant muscle contractions and twisting movements seen in torsion dystonia patients, whereas the majority of WT HtorA-expressing flies and control flies aged up to 12 days retained locomotor control under the same conditions (Supplementary Material, Movie A and B). Ubiquitous expression using a Tubulin-Gal4 driver produced very similar results (Fig. 2D ).
We observed a similar but somewhat less extreme phenotype when DE HtorA was expressed specifically in dopaminergic neurons (Fig. 2B) . It was necessary to age the DE HtorA-expressing flies for at least 12 days before 90 -100% of them lost locomotor control at 388C. The weaker phenotype of the flies expressing DE HtorA in dopaminergic neurons compared with the pan-neurally expressing flies suggests that the early onset and more severe phenotype requires DE HtorA expression in multiple types of neurons, which may include motor neurons.
Postsynaptic expression of DE HtorA in muscles also resulted in an age-and temperature-dependent loss of locomotor control with 90-100% of the DE HtorA-expressing flies remaining on the bottom of the vials at 388C after 9 days of age (Fig. 2C) .
In summary, expression of DE HtorA in Drosophila either in neurons or muscles can cause severe motor impairments as a function of age and environmental conditions, and the severity and age of onset of this phenotype vary depending on the spatial pattern of expression.
DE HtorA clusters have distinct subcellular localization
To further investigate how the DE HtorA protein clusters might contribute to the observed behavioral defects, we examined the subcellular distribution patterns of these clusters in wellcharacterized type I glutamatergic synapses in larval neuromuscular junction (NMJ). At type I glutamatergic synapses, we found that at least some of the postsynaptic DE HtorA clusters were localized near synaptic boutons in association with the subsynaptic reticulum (SSR). This is illustrated in Figure 3A and B, which shows three consecutive confocal slices for two sets of synaptic boutons labeled with specific antibodies for presynaptic membranes (anti-HRP) as well as for the SSR (anti-DLG).
Cell bodies of motor neurons in ventral nerve cords of larvae expressing DE HtorA in a pan-neural pattern contained HtorA clusters whose subcellular location partially overlapped with endosomes as marked by anti-HRS antibodies ( Fig. 3C1 -C3 ). We also observed some overlap between D HtorA clusters and endosomes in the motor neuron nerve bundles ( Fig. 3D ) and in muscles (data not shown). In contrast, no overlap was observed between WT or D18 bp HtorA proteins and the endosomal markers detected by anti-HRA antiserum (data not shown). We examined the localization of DE HtorA clusters at higher resolution using silver-enhanced immuno-EM analysis (Fig. 4) . In DE HtorA-expressing flies, silver-enhanced immunogold particles were observed to be associated with various cellular membranes at nerve terminals and in cell bodies. Examples of immunogold particles localized at a synapse, within the SSR, at the outer periphery of the nucleus, adjacent to In control experiments with larvae that did not express DE HtorA incubated with anti-HtorA antibodies or with larvae that did express DE HtorA incubated in the absence of antiHtorA antibodies, we observed fewer than 10% of the total particles seen in the experimental analysis, confirming the specificity of silver-enhanced anti-HtorA particles. Similar subcellular distribution patterns were observed with either presynaptic or postsynaptic expression of DE HtorA. The localization of DE HtorA clusters in synaptic regions, at nuclei and at endosomes suggests that the mutant protein could affect synaptic structure and function by interfering with one or more signaling pathways from synapses to nuclei and/or endosomes or vice versa.
Expression of DE HtorA induces morphological abnormalities at type I glutamatergic synapses
To determine whether DE HtorA expression resulted in any structural defects at synapses, we further examined type I glutamatergic synapses at the larval NMJ. We did not observe any significant differences in numbers of type I synaptic boutons in larvae expressing WT or DE HtorA in neurons (WT, 88.7+ 2.9; DE, 79.7 + 3.9, P . 0.08) or in muscles (WT, 78.0 + 4.0; DE, 87.2 + 3.6, P . 0.1) (Fig. 5A -D) . However, high-power confocal microscopy revealed altered morphologies of synaptic boutons expressing DE HtorA motor-neurons or muscles ( Fig. 5E -H) . Synaptic boutons expressing WT HtorA had a normal, smooth rounded appearance ( Fig. 5E and G) . In contrast, synaptic boutons expressing DE HtorA were noticeably enlarged and many of them had abnormal irregular shapes ( Fig. 5F and H).
To further characterize synaptic defects associated with DE HtorA expression, we performed an ultrastructural morphometric analysis on serial reconstructions obtained from two independent samples of boutons expressing WT or DE HtorA presynaptically. We examined a total of seven controls, 10 WT HtorA and nine DE HtorA boutons. There was no significant difference between control synaptic boutons and WT HtorA synaptic boutons (Table 1) . However, the length, surface area and volume of DE HtorA boutons were all significantly larger than those of controls or WT HtorA boutons ( Fig. 6A1 and A2 ; Table 1 ). In addition, expression of DE HtorA also caused ultrastructural abnormalities at regions of synaptic contact (Fig. 6C -F) . One such defect was the absence of synaptic vesicle pools near some synapses. Synapses in WT HtorA boutons were always surrounded by a pool of synaptic vesicles regardless of whether one or more presynaptic dense bodies (T-bars or 'active zones') were present ( Fig. 6B1 -B6) . However, about 12% of DE HtorA synapses (23/183) were devoid of synaptic vesicle pools and surrounded instead by a discrete clear zone (Fig. 6C1 -C6) . A second abnormality observed in synaptic regions was the presence of abnormal membrane structures that extended within synaptic vesicle pools ( Fig. 6D ; Table 1 ).
The abnormal membrane structure extended across the bouton, interconnecting two dense bodies on opposite sides. We observed similar abnormal membrane structures in all DE HtorA boutons examined. A third presynaptic abnormality was the presence of free dense bodies (Fig. 6E) , which are clear in a high-magnification inset. Despite their morphological resemblance to presynaptic dense bodies, these structures were free at the presynaptic terminals rather than anchored to the synaptic membrane (Table 1 ). In addition, the boutons expressing DE HtorA showed significantly increased synaptic density area compared with boutons expressing WT HtorA (Table 1) . These structural defects at the synaptic terminals in DE HtorA expressing boutons may account for the locomotor defects observed at elevated temperatures. Human
HtorA phenotypes
The presence of free dense bodies in presynaptic terminals associated with expression of DE HtorA was also recently observed in several Drosophila mutant affecting receptors or ligands of the TGF-b signaling pathway (26 -28) . The phenotypes are not identical however, as mutations in wishful thinking (wit ), which affects a type II BMP receptor causes additional synaptic defects including a decrease in levels of Fasciclin II and a distinctive detachment of synaptic membranes, which are not observed in larvae expressing DE HtorA (Fig. 6 and data not shown). Those observations suggest that DE HtorA expression might disrupt some part of the TGF-b signaling pathway to interfere with proper synaptic development. As DE HtorA clusters localized at synapses, SSR, endosomes and the nuclear periphery, it is possible that they disrupt trafficking of some components of TGF-b signaling from synapses to endosomes or nuclei. Mad and dSmad2 are known transcriptional effectors of the TGF-b pathway that regulates target gene expression to control cell proliferation (29) , neuronal remodeling during metamorphosis (30) and synaptic plasticity in type I glutamatergic NMJs (26, 27) . Studies indicate that dynamic changes in the molecular components of Smad complexes during trafficking from receptors to endosomes or nuclei are essential for eliciting proper responses (31, 32) . We hypothesized that DE HtorA interfered with trafficking of mothers against decapentaplegic (Mad) or Drosophila Smad2 (dSmad2) between synapses and nuclei or endosomes.
To explore the possibility that DE HtorA interfered with the TGF-b pathway, we examined the effect of overexpressing Mad or dSmad2 in a DE HtorA background. At the behavioral level, pan-neural expression of dSmad2 substantially rescued the locomotor defects caused by DE HtorA; at 388C, these flies remained as active as controls (C155-Gal4/þ) (Fig. 7A) . However, under the same condition, Mad overexpression did not suppress the DE HtorA behavioral defects. Pan-neural expression of dSmad2 alone had no effect on the flies compared with the control background (C155-Gal4/þ) (Fig. 7B) . Although DE HtorA behavioral phenotypes were suppressed by dSmad2 overexpression, mutating one copy of dSmad2 to Figure 4 . Subcellular localization of DE HtorA by immuno-EM analysis. DE HtorA-expressing larvae were dissected and incubated with anti-HtorA antiserum followed by addition of anti-rabbit IgG-conjugated 1 nm gold particles and processed for EM after silver enhancement. Localization was detected at synaptic densities (A, A1), within SSR (A2), at nuclear membranes (A3), associated with mitochondria (B) and at endosomes (C1 and C2). In (A) and (A1), DE HtorA expression was under the control of the C155 pan-neuronal driver. In the remaining panels expression was driven by the C57 muscle driver. n, Nucleus. reduce the gene dosage up to 50% did not enhance the phenotypes (Fig. 7B) . Expression of dSmad2 also rescued the DE HtorA morphological and ultrastructural phenotypes ( Fig. 6C ; Table 1 ). The volume, surface area and length of synaptic boutons were completely rescued as was synaptic area.
Other presynaptic abnormalities observed in DE HtorA animals including synapses with empty synaptic vesicle pools, presence of abnormal extended membrane structures and the presence of free dense bodies were eliminated or significantly reduced by expression of dSmad2 (Table 1) . Furthermore, we found that expression of human Smad2, a human homologues of dSmad2 (33), rescued behavioral abnormalities as does dSmad2 (Fig. 7) . Rescue of DE HtorA phenotypes by expression of human or Drosophila Smad2 was not due to indirect effect on DE HtorA expression as the levels of DE HtorA remained unaltered in the appeared backgrounds (data not shown).
DISCUSSION
The major goal of the present investigation was to develop a Drosophila model for early onset torsion dystonia. Our most significant finding is that expression of DE HtorA but not WT HtorA either in the nervous system or in muscles of Drosophila results in severely impaired motor behavior. Affected flies exhibit loss of coordination, inability to stand upright, spasmodic activity, leg kicking and held out wings, all of which are reminiscent of the uncontrolled muscle contractions characteristic of early onset torsion dystonia in humans. Interestingly, the DE HtorA-expressing flies manifest these behavioral abnormalities only upon acute exposure to 388C. This result is consistent with the proposed second-hit model to explain why only about 30-40% of individuals heterozygous for the DYT1 mutation develop the phenotypic manifestations of early onset torsion dystonia (9, 15, 16) . According to this model, expression of the mutated DE HtorA protein in heterozygous individuals predisposes them towards the disease state making these individuals susceptible to a second hit, such as exposure to some environmental stress or the presence of another genetic factor that triggers complete onset of the disease. In fact, we have found several phenotypic abnormalities associated with DE HtorA expression that are not temperature-dependent and that could underlie the observed behavioral defects at elevated temperatures. Similar to what has been observed in transfected human cells in culture (9,10), we found that DE HtorA forms protein aggregates when expressed in Drosophila neurons or muscles (Figs 1 and 3) . Localization of DE HtorA protein clusters at the confocal microscopy level revealed that some of these clusters were associated with synaptic boutons particularly in the region of the SSR or colocalized with endosomal markers (Fig. 3) . In addition to confirming the presence of DE HtorA in SSR and in association with endosomes, immuno-EM studies demonstrated that DE HtorA was also found associated with synaptic densities and the nuclear envelope (Fig. 4) . The subcellular localization of DE HtorA raises the possibility that it could interfere with a signal transduction pathway between synapses and nuclei that is required for proper synaptic development and function. No. of boutons (no. of samples) 2 (7) 10 (2) 9 (2) 9 (2) Volume (mm Detailed confocal and electron microscopic examination of synaptic boutons revealed a number of structural defects in DE HtorA-expressing larvae (Figs 5 and 6 ). The presence of free dense bodies was particularly intriguing because this phenotype has only previously been reported for mutations that perturb the TGF-b signaling pathway. TGF-b signaling pathways regulate many developmental and physiological processes both in vertebrates and invertebrates and perturbations in these signaling pathways have been implicated in a wide array of pathological conditions (34) . Recent studies in Drosophila have demonstrated that proper development and plasticity of synaptic boutons in the larval NMJ is dependent on TGF-b pathway, at least in part, by wit (26, 27) . Downregulation of TGF-b receptors at synaptic terminals via endocytotic internalization appears to be an important mechanism for controlling synaptic plasticity (35) . In addition, experimental evidence suggests that retrograde transport of signaling to endosomes containing the activated TGF-b receptor/Smads complexes from synaptic terminal or membranes to cell body might also be an essential aspect of the TGF-b signaling mechanism to control development and function of the synapses (27, 36) .
The existence of a known signaling pathway from synapse to nucleus via endosomal intermediates that regulates growth and development of synapses was of particular interest in the context of the present work because DE HtorA expression perturbs synaptic development and DE HtorA protein aggregates are found at precisely those subcellular locationssynaptic terminals, endosomes and nuclei-where they could most readily interfere with such a signaling pathway. This possibility was further strengthened with the finding that the production of free dense bodies in motor terminals is associated with DE HtorA expression as it is with mutations of components of the TGF-b signaling (26, 27) .
To investigate further whether the phenotypic abnormalities associated with DE HtorA expression were, in fact, dependent on perturbing the TGF-b signaling, we asked whether these phenotypes could be modified by overexpression of Mad or dSmad2, the transcriptional effectors of the TGF-b pathway (26 -29) . Remarkably, we found that pan-neural overexpression of dSmad2, but not Mad, substantially suppressed the defects in locomotor behavior as well as in synaptic morphology in DE HtorA animals.
As the locomotor defects observed in DE HtorA flies at elevated temperatures bear some striking resemblance with the phenotype of torsion dystonia patients the possible involvement of common mechanisms does not seem unreasonable. Moreover, a variety of data demonstrate that, as in Drosophila, TGF-b signaling is important for the development of the mammalian nervous system and, in particular, plays an essential role in synaptic development and plasticity (34, 37) . We also showed that expression of hSmad2 rescues abnormal behaviors as that of dSmad2 in flies (Fig. 7) . Consequently, the possibility that the underlying mechanism of early onset torsion dystonia in humans involves a disruption of TGF-b signaling merits further investigation. Early onset torsion dystonia is one of many severe complex neurobehavioral disorders caused by the interaction of multiple genes, or by a combination of genetic and environmental risk factors (14, 15) . As there is significant variation in phenotype manifested by human patients, identification of susceptible genes that may be responsible for triggering the severe symptoms is important in seeking an adequate treatment (1 -5) . In addition to examining human patients, another strategy is to find susceptible genes by taking advantage of an established animal model. As the studies reported here demonstrate, further studies in this Drosophila model for early onset torsion dystonia should provide unique opportunities to obtain additional novel information about the underlying cellular and molecular mechanisms of this disorder.
MATERIALS AND METHODS
Fly genetics
Flies were raised on standard medium at 258C unless otherwise specified.
Generating human TorsinA transgenic flies. The WT HtorA open reading frame was amplified by polymerase chain reaction (PCR) from a human fetal brain cDNA library (Clontech, CA, USA). Amplified PCR products were subcloned into pBlueScript II KS 2 (Stratagene, CA, USA) and DNA sequences were confirmed. For generating DE302/303 forms of HtorA, Kunkel mutagenesis was employed (38) . Briefly, a DGAG primer (5 0 -GTA AGC AGA GTG GCT GAG Ã ATG ACA TTT TTC CCC-3 0 ) missing a glutamic acid codon at amino acid position 302/303 (indicated by asterisk) was designed. Single-stranded DNAs of pBlueScript II KS 2 containing HtorA were generated, purified and annealed with DGAG primers. Plasmids containing DGAG were confirmed by DNA sequencing. For generating 18 bp deletion mutant forms (DF323-Y328) of HtorA, three rounds of PCR were performed using three different overlapping primers (5 0 -CTT TAT CTG AGA AAA CTC TCT CCT CTT TGG GGA AA-3 0 , 5 0 -GGT GAA CAC CGT TTT GCA GCC TTT ATC GCC TTT ATC TGA GAA AA-3 0 , 5 0 -TCG TAG TAA TAA TCA ATC TTG GTG AAC ACC GTT TT-3 0 ). Final PCR products deleted for the desired 18 bp were confirmed by DNA sequencing. Open reading frames of WT, DE302/303 and DF323-Y328 of HtorA were cloned into pUAST-germline transformation vectors. DNA sequences were confirmed again and typical germline transformation technique procedure was followed (19) . Several independent fly lines were generated for each construct. Similar levels of expressions and phenotypic properties were observed for independent isolates.
Gal4 drivers. Expression of UAS -HtorA constructs was driven by various Gal4 drivers including a pan-neuronal (C155) Gal4 driver (21), a 3,4-dihydroxyphenylalanine-Ldecarboxylase (Ddc)-Gal4 driver (22) , a muscle-specific Gal4 driver (24) and a Tubulin-Gal4 driver (39).
Mad, dSmad2 or hSmad2 overexpression. To test suppression by Mad, hSmad2 or dSmad2, UAS-Mad, UAS-hSmad2 (33) (gifts from Dr Stewart Newfeld, Arizona State University) or UAS-dSmad2 flies (30) (a gift from Dr Tzumin Lee, University of Illinois) were crossed to C155-Gal4; UAS-DE HtorA/ SM6b to generate C155-Gal4/UAS-Mad; UAS-DE HtorA, C155/UAS-hSmad2; UAS-DE HtorA/UAS-hSmad2 or C155-Gal4; UAS-DE HtorA/UAS-dSmad2 flies, which expressed both DE HtorA and Mad, hSamd2 or dSmad2 pan-neuronally. UAS-dSmad2 flies were crossed with C155-Gal4 to generate flies overexpressing dSamd2 in neurons to determine if there were any effects on behavior. To examine whether or not compromising TGF-b pathway yielded any obvious phenotypes, dSmad2 1 /FM7c flies (gift from Dr Tzumin Lee, University of Illinois) were crossed with C155-Gal4;UAS-DE HtorA flies. C155-Gal4/dSmad2
1 ;UAS-DE HtorA flies were collected and tested for locomotor behavior as described in the following text.
For EM analysis, UAS-dSmad2 females were crossed to C155-Gal4/Y; UAS-DE HtorA/SM6b-kr-GFP males to separate C155-Gal4/þ; UAS-DE HtorA/UAS-dSmad2 larvae, which were identified as female larvae lacking GFP expression.
Antibodies and immunocytochemistry
His-tagged human TorsinA recombinant peptides (residues 61 -332) were expressed in Escherichia coli M15 carrying the pREP4 plasmid (Qiagen). The fusion proteins were purified using Ni-NTA beads (Qiagen) and SDS -PAGE and then injected into rabbits for antibody production.
Procedures for immunocytochemistry are as described in literature (24) . The following antibodies were used: (1) Figure 1A3 , rabbit or goat anti-human TorsinA antibodies were incubated with human TorsinA peptides (Santa Cruz Biotechnology, Inc., 200 ng/1 ml). Donkey anti-rabbit Alexa 568, anti-guinea pig Alexa 488 and anti-mouse Alexa 488 were used as a secondary antibodies with 1 : 200 dilutions (Molecular Probes, OR, USA). Confocal images were taken on a Bio-Rad MRC 1024 confocal laser scanning microscope (BioRad, UK) and processed using Adobe Photoshop 5.5 (Adobe, CA, USA).
The number of synaptic boutons in larval muscles 6 and 7 (segment A2) in experimental and control larvae was counted under an epi-fluorescence microscope. Two sample t-tests were performed using Minitab software.
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Behavioral assays
Each group of flies tested for locomotor abilities consisted of five males and five females of the same age. After each group of flies was transferred into a vial, the vial was placed in pre-heated 388C water bath, and observed continuously over a 10 min period. Flies retaining locomotor abilities were considered to be those walking on the sides or tops of vials, rather than being immobilized or remaining on the bottom, at each time point. Tested flies were collected from three different independent crosses and raised at 308C to accelerate aging. Genetic backgrounds of Gal4 drivers or DE HtorA expressing flies were compared with WT HtorA expression flies. Two sample t-tests were performed using Minitab software.
Silver-enhanced anti-human TorsinA immuno-gold electron-microscopy Control and experimental larvae were dissected in Ca 2þ free saline and then fixed with 0.005% glutaraldehyde and 4% paraformaldehyde in 0.1 M phosphate buffer (pH. 7.2) for 1 h. Samples were marked and processed in the same well. After washing three times with 0.1 M phosphate buffer (pH. 7.2) with 0.2% Triton-X 100 (PBT), samples were incubated with anti-human TorsinA antisera (diluted 1: 1000) overnight at 48C. Samples were washed three times with PBT and then with 4% bovine serum albumin and 4% normal goat serum to prevent non-specific binding. Samples were incubated with 1: 200 diluted 1 nm gold conjugated anti-rabbit IgG (BBInternational, UK; diluted 1: 200) for 2 h at RT with shaking. After washing three times with PBT, silver enhancement was performed according to manufacturer's directions for 10 min (BBInternational, UK). Samples were washed with H 2 O for 5 min and then postfixed with 1% glutaraldehyde and 4% paraformaldehyde in 0.1 M PB overnight.
Samples were subsequently processed as previously described (24) . Two independent controls were performed to confirm the specificity of silver-enhanced particles. Larvae that did not express DE HtorA antiserum were dissected and DE HtorA-expressing larvae incubated without anti-HtorA antiserum were processed simultaneously with experimental samples. Thin sections (100 nm) were collected on membrane coated one-slot grids and double stained with lead citrate and uranyl acetate solution. Silver-enhanced anti-HtorA positive particles were photographed at 25 000Â by a Megaplus digital camera (Kodak, USA) attached to a Philips CM120 Scanning Transmission Electron Microscope (STEM) at 60 kV.
Transmission electron microscopy
The procedure for TEM and morphometric analysis of synaptic boutons have been previously described (24) . For this analysis, only type Ib glutamatergic synaptic boutons on muscles 6 and 7 (segment A2) were serially thin-sectioned (100 nm). Thickness of thin sections was confirmed by examining wrinkles of thin sections under TEM. Serial images of type Ib boutons were taken at 15 000Â with a Megaplus digital camera (Kodak, USA) attached to a Philips CM120 STEM at 60 kV. To determine length, surface area and volume of boutons, and area of synapses, serial reconstructions of synaptic boutons were made by carefully aligning digital images. The relevant features of synaptic boutons such as bouton surfaces and synaptic densities were digitalized using Adobe Photoshop and analyzed with NIH image software. Two different samples of each genotype were used for morphometric analysis. Minitab software was used to perform two sample t-tests.
